Science Explorer Back to mapMap

Most cited papers in Ocular Oncology and Treatments

What are the most cited papers in Ocular Oncology and Treatments?

The most cited paper in Ocular Oncology and Treatments is "Mutation and Cancer: Statistical Study of Retinoblastoma" (Alfred G. Knudson, 1971), with 7,700 citations. Next come "The Human Papilloma Virus-16 E7 Oncoprotein Is Able to Bind to the Retinoblastoma Gene Product" (3,072) and "A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma" (2,994).

Showing 50 of 100 papers. Every paper with more than 574 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Mutation and Cancer: Statistical Study of Retinoblastoma Alfred G. Knudson · Proceedings of the National Academy of Sciences Open access Apr 1971 7,700
2 The Human Papilloma Virus-16 E7 Oncoprotein Is Able to Bind to the Retinoblastoma Gene Product Nicholas J. Dyson, Peter M. Howley, Karl Münger et al. · Science 17 Feb 1989 3,072
3 A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma Stephen Henry Friend, René Bernards, Snezna Rogelj et al. · Nature Open access Oct 1986 2,994
4 Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib Caroline Robert et al. · New England Journal of Medicine Open access 16 Nov 2014 2,718
5 Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma Keith T. Flaherty et al. · New England Journal of Medicine Open access 14 Jun 2012 2,179
6 Expression of recessive alleles by chromosomal mechanisms in retinoblastoma Webster K. Cavenee, Thaddeus P. Dryja, Robert A. Phillips et al. · Nature Oct 1983 1,953
7 Effects of an Rb mutation in the mouse Tyler Jacks, Amin Fazeli, Earlene M. Schmitt et al. · Nature Sep 1992 1,779
8 The Molecular Genetics of Cancer J. Michael Bishop · Science 16 Jan 1987 1,716
9 The RB and p53 pathways in cancer Charles J. Sherr, Frank P. McCormick · Cancer Cell Open access Aug 2002 1,701
10 The National Cancer Data Base report on cutaneous and noncutaneous melanoma Alfred E. Chang, Lucy Hynds Karnell, Herman R. Menck · Cancer Open access 15 Oct 1998 1,676
11 Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi Catherine D. Van Raamsdonk, Vladimir Bezrookove, Gary Green et al. · Nature Open access 10 Dec 2008 1,655
12 Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas J. William Harbour, Michael D. Onken, Elisha D. O. Roberson et al. · Science Open access 4 Nov 2010 1,511
13 Mutations in GNA11 in Uveal Melanoma Catherine D. Van Raamsdonk, Klaus Griewank, Michelle B. Crosby et al. · New England Journal of Medicine Open access 17 Nov 2010 1,503
14 SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene James A. DeCaprio, John W. Ludlow, James Figge et al. · Cell Jul 1988 1,488
15 The E2F transcription factor is a cellular target for the RB protein Srikumar Chellappan, Scott W. Hiebert, Maria M. Mudryj et al. · Cell Jun 1991 1,455
16 Human Retinoblastoma Susceptibility Gene: Cloning, Identification, and Sequence Wen‐Hwa Lee, Robert Bookstein, Frank Hong et al. · Science 13 Mar 1987 1,438
17 Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product Peter Whyte, Karen J. Buchkovich, Jonathan M. Horowitz et al. · Nature Jul 1988 1,437
18 Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma Mark B. Faries et al. · New England Journal of Medicine Open access 7 Jun 2017 1,415
19 Uveal Melanoma: Trends in Incidence, Treatment, and Survival Arun D. Singh, Mary E. Turell, Allan K. Topham · Ophthalmology 28 Jun 2011 1,286
20 Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006) Jacob Schachter, Antoni Ribas, Georgina Venetia Long et al. · The Lancet 16 Aug 2017 1,256
21 p53: A Frequent Target for Genetic Abnormalities in Lung Cancer Takashi Takahashi, Marion M. Nau, Itsuo Chiba et al. · Science 27 Oct 1989 1,232
22 The International Vitreomacular Traction Study Group Classification of Vitreomacular Adhesion, Traction, and Macular Hole Jay S. Duker, Peter K. Kaiser, Susanne Binder et al. · Ophthalmology 17 Sep 2013 1,203
23 The Rb/E2F pathway: expanding roles and emerging paradigms J. William Harbour, Douglas C. Dean · Genes & Development Open access Oct 2000 1,178
24 The Five-year Incidence and Progression of Age-related Maculopathy Ronald Klein, Ronald Klein, Susan C. Jensen et al. · Ophthalmology 1997 1,138
25 Functional Inactivation of the Retinoblastoma Protein Requires Sequential Modification by at Least Two Distinct Cyclin-cdk Complexes Ante S. Lundberg, Robert A. Weinberg · Molecular and Cellular Biology Open access Feb 1998 1,078
26 Very Long-Term Prognosis of Patients with Malignant Uveal Melanoma Emma Kujala, Teemu Ma¨kitie, Tero Kivelä · Investigative Ophthalmology & Visual Science 24 Oct 2003 1,064
27 Survey of 1264 patients with orbital tumors and simulating lesions Jerry A. Shields, Carol L. Shields, Richard Scartozzi · Ophthalmology May 2004 1,052
28 Functional interactions of the retinoblastoma protein with mammalian D-type cyclins Mark E. Ewen, Hayla K. Sluss, Charles J. Sherr et al. · Cell May 1993 1,034
29 Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma Genevieve Schindler, David Capper, Jochen Meyer et al. · Acta Neuropathologica 28 Jan 2011 1,033
30 The retinoblastoma protein is phosphorylated during specific phases of the cell cycle Karen J. Buchkovich, Linda Duffy, Ed Harlow · Cell 22 Sep 1989 1,029
31 Requirement for a functional Rb-1 gene in murine development Alan Richard Clarke, Els Robanus Maandag, M van Roon et al. · Nature Sep 1992 1,015
32 Regulation of retinoblastoma protein functions by ectopic expression of human cyclins Philip W. Hinds, Sibylle Mittnacht, Vjekoslav Dulić et al. · Cell Sep 1992 1,014
33 Non-syndromic retinitis pigmentosa Sanne K. Verbakel, Ramon A. C. van Huet, Camiel J. F. Boon et al. · Progress in Retinal and Eye Research Open access 27 Mar 2018 1,011
34 Survey of 520 Eyes with Uveal Metastases Carol L. Shields, Jerry A. Shields, Nicole Groß et al. · Ophthalmology Aug 1997 1,008
35 The international incidence of childhood cancer D M Parkin, Charles A. Stiller, Gerald J. Draper et al. · International Journal of Cancer 15 Oct 1988 1,003
36 Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts David A. Alcorta, Yue Xiong, Dawn E. Phelps et al. · Proceedings of the National Academy of Sciences Open access 26 Nov 1996 994
37 Cellular mechanisms of tumour suppression by the retinoblastoma gene Deborah L. Burkhart, Julien Sage · Nature reviews. Cancer ReviewOpen access 24 Jul 2008 989
38 Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation Phang‐Lang Chen, Peter Scully, Jin‐Yuh Shew et al. · Cell Sep 1989 983
39 Tandem Duplication Producing a Novel Oncogenic BRAF Fusion Gene Defines the Majority of Pilocytic Astrocytomas David Jones, Sylvia Kocialkowski, Lu Liu et al. · Cancer Research Open access 30 Oct 2008 958
40 Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma A. Gordon Robertson et al. · Cancer Cell Open access211 authors Aug 2017 932
41 The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element James A. DeCaprio, John W. Ludlow, Dennis C. Lynch et al. · Cell 22 Sep 1989 928
42 p14ARF links the tumour suppressors RB and p53 Stewart Bates, Andrew C. Phillips, Paula A. Clark et al. · Nature Sep 1998 922
43 Abnormalities in Structure and Expression of the Human Retinoblastoma Gene in SCLC J. William Harbour, Shinn-Liang Lai, Jacqueline Whang‐Peng et al. · Science Open access 15 Jul 1988 919
44 Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma Paul Nathan et al. · New England Journal of Medicine Open access 22 Sep 2021 916
45 Frequency of TERT promoter mutations in human cancers João Vinagre et al. · Nature Communications Open access 26 Jul 2013 913
46 TUMOR DORMANCY IN VIVO BY PREVENTION OF NEOVASCULARIZATION Michael A. Gimbrone, Stephen B. Leapman, Ramzi S. Cotran et al. · The Journal of Experimental Medicine Open access Aug 1972 907
47 Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16 Jiri Lukas, David A.D. Parry, Louise Aagaard et al. · Nature Jun 1995 904
48 Inverted Internal Limiting Membrane Flap Technique for Large Macular Holes Zofia Michalewska, Janusz Michalewski, Ron Afshari Adelman et al. · Ophthalmology 12 Jun 2010 869
49 Uveal melanoma Martine Johanna Jager, Carol L. Shields, Colleen M. Cebulla et al. · Nature Reviews Disease Primers Review 9 Apr 2020 867
50 Dermoscopy compared with naked eye examination for the diagnosis of primary melanoma: a meta-analysis of studies performed in a clinical setting M. Vestergaard, Petra Macaskill, Phoebe E Holt et al. · British Journal of Dermatology Review Jun 2008 867

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.